Outpatient use of low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity

Thrombosis and Haemostasis

Volumn 82, Issue 3, 1999, Pages 1008-1010

  Savage, K J ^a   Wells, P S ^c   Schulz, V ^a   Goudie, D ^c   Morrow, B ^a   Cruickshank, M ^a,b   Kovacs, Michael J ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARM; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL STANDARD UNIT; LUNG EMBOLISM; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTPATIENT; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032821861     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614319     Document Type: Article

References (25)

1. Horattas MC, Wright DJ, Fenton AH, Evans DM, Oddi MA, Kamienski RW, Shields EF. Changing concepts of deep venous thrombosis of the upper extremity - report of a series and review of the literature. Surgery 1988; 104: 561-7.
2. Donayre CE, White GH, Mehringer SM, Wilson SE. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis. Am J Surg 1986; 152: 179-84.
3. Harley DP, White RA, Nelson RJ, Mehringer CM. Pulmonary embolism secondary to venous thrombosis of the arm. Am J Surg 1984; 147: 221-4.
4. Aburahma AF, Sadler DL, Robinson PA. Axillary-subclavian vein thrombosis. Changing patterns of etiology diagnostic and therapeutic modalities. Am Surg 1991; 57: 101-7.
5. Becker DM, Philbrick JT, Walker FB. Axillary and subclavian vein thrombosis: Prognosis and treatment. Arch Intern Med 1991; 151: 1934-43.
6. Monreal M, Lafoz E, Ruiz J, Vails R, Alastrue A. Upper extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 1991; 99: 280-3.
7. Hill S, Berry RH. Subclavian vein thrombosis: A continuing challenge. Surgery 1990; 108: 1-9.
8. Hung SS. Deep vein thrombosis of the arm associated with malignancy. Cancer 1989; 64: 531-5.
9. Prandoni P, Polistena P, Bernardi E, Cogo A, Casara D, Verlato F, Angelini F, Simioni P, Signorini GP, Benedetti L, Girolami A. Upper extremity deep vein thrombosis, Risk factors, diagnosis and complications. Arch Intern Med 1997; 157: 57-62.
10. Hull RD, Rosckob G, Pineo GF. Subcutaneous LMWH compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. New Engl J Med 1992; 326: 975-88.
11. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH, Bossuyt PMM, deHaes H, van den Belt AGM, Sagnard L, d'Azemar P, Büller HR, for the Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. New Engl J Med 1996; 334: 682-7.
12. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S, Willan A. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. New Engl J Med 1996; 334: 677-81.
13. Hirsh J, Siragusa S, Cosmi B, Ginsberg JS. Low molecular weight heparins in the treatment of patients with acute venous thromboembolism. Thromb Haemost 1995; 74: 360-3.
14. Lensing AWA, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low molecular weight heparins: A meta-analysis. Arch Intern Med 1995; 155: 601-7.
15. Prandoni P, Lensing AWA, Buller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, Cate JWT. Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal deep vein thrombosis. Lancet 1992; 339: 441-5.
16. Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, Laurent M, Hirsch JL, Ferrari E, Bosson JL, Mottier D, Beau B. A comparison of low-molecular weight heparin with unfractionated heparin for acute pulmonary embolism. New Engl J Med 1997; 337: 663-9.
17. The Columbus Investigators. Low molecular weight heparin is an effective and safe treatment for deep-vein thrombosis and pulmonary embolism. New Engl J Med 1997; 337: 657-62.
18. Wells PS, Kovacs MJ, Forgie MA, Bormanis J, Goudie D, Morrow B, Kovacs J. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low molecular weight heparin: A comparison of patient self-injection to home care injection. Arch Intern Med 1998; 158: 1809-12.
19. Rodger M, Bredeson C, Wells PS, Beck J, Kearns B, Huebsch LB. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis. Can Med Assoc J 1998; 159: 931-8.
20. Kovacs MJ, Cruickshank M, Wells PS, Kim H, Chin-Yee I, Morrow B, Boyle E, Kovacs J. Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 1998; 28: 62-9.
21. Koot HWJ, Veen HF. Local thrombolytic therapy for axillary subclavian vein thrombosis. Neth J Surg 1991; 43: 71-4.
22. Roos DB. Axillary-subclavian vein occlusion. Vascular Surgery, ed. WB Saunders, Philadelphia 1984: pp. 1385-93.
23. Swinton NW, Edgett JW, Hall RJ. Primary subclavian - axillary vein thrombosis. Circulation 1968; 38: 737-45.
24. Ameli FM, Minas T, Weiss M, Provan JL. Consequences of "conservative conventional management of axillary vein thrombosis". Canadian Journal of Surgery 1987; 30: 167-9.
25. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-17.